Key result
Higher atherogenic index of plasma is linked to ~179% higher risk of CAD.
Why the study?
Is a higher atherogenic index of plasma associated with increased risk, severity, and poorer prognosis of coronary artery disease?
Meta-Analysis
Is a higher atherogenic index of plasma associated with increased risk, severity, and poorer prognosis of coronary artery disease?
Odds Ratio: 2.79 (95% CI 1.75–4.45)
p-value: p=<0.00001
Elevated atherogenic index of plasma is strongly associated with increased CAD risk, greater severity, and poorer prognosis, highlighting its potential utility as a biomarker for cardiovascular risk stratification.
Supports AIP for CAD risk stratification; extends observational meta-analyses but should not yet change practice.
BACKGROUND: Atherogenic index of plasma (AIP), a novel logarithmic index that combines fasting triglyceride and high-density lipoprotein cholesterol concentrations, is associated with the burden of atherosclerosis. This study aimed to evaluate the relationship between AIP and coronary artery disease (CAD) risk, severity, and prognosis in populations with and without established CAD. METHODS: PubMed, Embase, and Web of Science were systematically searched from the inception of each database to August 13, 2024. Cross-sectional studies, case-control studies, and prospective or retrospective cohort studies using multivariate analysis were included. Given that the true effect size may differ across studies, a random-effects model for all analyses was applied. RESULTS: Fifty-one observational studies were included in this study. Patients with higher AIP were more likely to have CAD (odds ratio (OR): 2.79, 95% CI 1.75-4.45, P < 0.00001). Furthermore, these patients were more likely to have coronary artery calcification (OR: 2.28, 95% CI 1.74-3.00, P < 0.00001), multivessel CAD (OR: 2.04, 95% CI 1.50-2.77, P < 0.00001), and an increased risk of plaque progression (OR: 1.49, 95% CI 1.17-1.91, P = 0.001). In populations without established CAD, higher AIP levels were associated with an increased risk of Major adverse cardiovascular events (MACE) (hazard ratio (HR): 1.28, 95% CI 1.22-1.35, P < 0.00001). Interestingly, this finding was consistent in patients presenting with acute coronary syndrome (HR: 1.59, 95% CI 1.33-1.89, P < 0.00001) and patients with chronic coronary syndrome or stable CAD (HR: 1.65, 95% CI 1.15-2.37, P = 0.007). CONCLUSIONS: This meta-analysis demonstrates that elevated AIP is strongly associated with increased CAD risk, greater severity, and poorer prognosis in populations with and without established CAD. However, more studies are needed to evaluate the predictive performance and determine the optimal cut-off for AIP in different populations.
No takes yet. Share an insight, caveat, or question.
Assempoor et al. (2025) conducted a meta-analysis in Coronary artery disease (CAD). Higher atherogenic index of plasma (AIP) vs. Lower atherogenic index of plasma (AIP) was evaluated on Presence of coronary artery disease (CAD) (OR 2.79, 95% CI 1.75-4.45, p=<0.00001). Higher atherogenic index of plasma is significantly associated with an increased risk of coronary artery disease (OR 2.79).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: